Changes in Electroretinogram Oscillatory Potentials During Dark Adaptation
- 66 Downloads
- 3 Citations
Abstract
Purpose
To investigate changes in the oscillatory potentials (OPs) of electroretinograms (ERGs) during dark adaptation (DA).
Methods
ERGs were recorded from ten normal subjects. Following 15 min of light adaptation, ERGs were recorded every 30 s for 20 min to follow the changes in the OPs during the course of DA. A 20-ms, 560-nm rectangular pulse of light was presented at 3.3 Hz to elicit the ERGs.
Results
The latencies of OP1 and OP2 did not change significantly, but the amplitudes decreased slightly during DA. OP3 was not observed at 30 s, but appeared after 1 min of DA between OP2 and OP4. Similar results were obtained with stimulus durations of 10 to 100 ms in 10-ms steps. The amplitude of OP3 increased to 10 min of DA and then plateaued.
Conclusion
The characteristics of OP3, which increases during DA, indicate that it is probably related to rod activity. Jpn J Ophthalmol 2005;49:420–422 © Japanese Ophthalmological Society 2005
Key words
cone activity dark adaptation electroretinogram oscillatory potential rod activityPreview
Unable to display preview. Download preview PDF.
References
- 1.Peachey, NS, Alexander, KR, Fishman, GA 1987Rod and cone system contributions to oscillatory potentials: an explanation for the conditioning flash effectVision Res27859866CrossRefPubMedGoogle Scholar
- 2.Lachapelle, P 1987Analysis of the photopic electroretinogram recorded before and after dark adaptationCan J Ophthalmol22354361PubMedGoogle Scholar
- 3.King-Smith, PE, Loffering, DH, Jones, R 1986Rod and cone ERGs and their oscillatory potentialsInvest Ophthalmol Vis Sci27270273PubMedGoogle Scholar
- 4.Coupland, S 1987Oscillatory potential changes related to stimulus intensity and light adaptationDoc Ophthalmol66195205CrossRefPubMedGoogle Scholar
- 5.Rousseau, S, Lachapelle, P 1999The electroretinogram recorded at the onset of dark-adaptation: understanding the origin of the scotopic oscillatory potentialsDoc Ophthalmol99135150CrossRefPubMedGoogle Scholar